Literature DB >> 33495854

[Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases-relative all clear through consistent testing].

I Andreica1, B Guminski1, J Sokolar1, A Patru1, X Baraliakos1, J Braun2.   

Abstract

The severe acute respiratory coronavirus type 2 (SARS-CoV-2) pandemic is keeping most countries of the world in suspense. In Germany the prevalence of SARS-CoV‑2 infections is under 2% but for weeks the numbers in Germany have also been increasing. The care in rheumatology was temporarily impaired by the first wave of the pandemic. This article reports the infection situation in the largest specialized rheumatology clinic in Germany, the Rheumatism Center Ruhrgebiet, because recently during the second wave for the first time several SARS-CoV‑2 infections occurred here over one weekend, which led to considerable anxiety in many of those involved. The situation could be clarified by consistent testing of patients and personnel with the rapid antigen test and the situation could be mollified. Ultimately, only a few persons were tested positive and the courses by the patients have so far remained bland. This shows the effectiveness of the protective hygiene measures consistently implemented since April.

Entities:  

Keywords:  COVID-19; Corona hygiene concept; Hospital for rheumatic diseases; Pandemic; SARS-CoV-2 antigen test

Year:  2021        PMID: 33495854      PMCID: PMC7832413          DOI: 10.1007/s00393-021-00959-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  5 in total

1.  Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.

Authors:  Milena A Gianfrancesco; Liza A Leykina; Zara Izadi; Tiffany Taylor; Jeffrey A Sparks; Carly Harrison; Laura Trupin; Stephanie Rush; Gabriela Schmajuk; Patricia Katz; Lindsay Jacobsohn; Tiffany Y Hsu; Kristin M D'Silva; Naomi Serling-Boyd; Rachel Wallwork; Derrick J Todd; Suleman Bhana; Wendy Costello; Rebecca Grainger; Jonathan S Hausmann; Jean W Liew; Emily Sirotich; Paul Sufka; Zachary S Wallace; Pedro M Machado; Philip C Robinson; Jinoos Yazdany
Journal:  Arthritis Rheumatol       Date:  2021-02-02       Impact factor: 10.995

2.  Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al.

Authors:  Ioana Andreica; David Kiefer; Guenther A Rezniczek; Robert Jast; Bjoern Buehring; Uta Kiltz; Xenofon Baraliakos; Juergen Braun
Journal:  Ann Rheum Dis       Date:  2020-07-30       Impact factor: 27.973

3.  Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets.

Authors:  Chantal B F Vogels; Anderson F Brito; Anne L Wyllie; Joseph R Fauver; Isabel M Ott; Chaney C Kalinich; Mary E Petrone; Arnau Casanovas-Massana; M Catherine Muenker; Adam J Moore; Jonathan Klein; Peiwen Lu; Alice Lu-Culligan; Xiaodong Jiang; Daniel J Kim; Eriko Kudo; Tianyang Mao; Miyu Moriyama; Ji Eun Oh; Annsea Park; Julio Silva; Eric Song; Takehiro Takahashi; Manabu Taura; Maria Tokuyama; Arvind Venkataraman; Orr-El Weizman; Patrick Wong; Yexin Yang; Nagarjuna R Cheemarla; Elizabeth B White; Sarah Lapidus; Rebecca Earnest; Bertie Geng; Pavithra Vijayakumar; Camila Odio; John Fournier; Santos Bermejo; Shelli Farhadian; Charles S Dela Cruz; Akiko Iwasaki; Albert I Ko; Marie L Landry; Ellen F Foxman; Nathan D Grubaugh
Journal:  Nat Microbiol       Date:  2020-07-10       Impact factor: 30.964

4.  Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study.

Authors:  Piercarlo Sarzi-Puttini; Daniela Marotto; Roberto Caporali; Carlo Maurizio Montecucco; Ennio Giulio Favalli; Franco Franceschini; Michela Fredi; Silvia Balduzzi; Chiara Bazzani; Sara Bongiovanni; Valeria Giorgi; Alberto Batticciotto; Antonella Cappelli; Patrizia Balzarini; Lorenzo Dagna; Silvia Sartorelli; Viviana Ravagnani; Silvia Tamanini; Sonia Farah; Paola Faggioli; Laura Castelnovo; Alfredo Maria Lurati; Massimo Galli; Fausto Salaffi
Journal:  J Autoimmun       Date:  2020-09-22       Impact factor: 7.094

  5 in total
  1 in total

1.  Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.

Authors:  Fatih Karaarslan; Fulya Demircioğlu Güneri; Sinan Kardeş
Journal:  Rheumatol Int       Date:  2021-05-12       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.